EUVIMEDEUVIMED entdecken
Studienprotokoll

Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial

Rebekah W Moehring, Michael E Yarrington, Bobby G Warren, Yuliya Lokhnygina, Erica Atkinson, Allison Bankston, Julia Collucio, Michael Z David, Angelina E Davis, Janice Davis, Brandon Dionne, April P Dyer und 18 weitere

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · 433-442

DOI: 10.1093/cid/ciac787 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Clinical Infectious Diseases, online erschienen am 28.09.2022. Verfasst von Rebekah W Moehring und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Infectious Diseases, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Sepsis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis guidelines recommend daily review to de-escalate or stop antibiotics in appropriate patients. This randomized, controlled trial evaluated an opt-out protocol to decrease unnecessary antibiotics in patients with suspected sepsis.

Methods

We evaluated non–intensive care adults on broad-spectrum antibiotics despite negative blood cultures at 10 US hospitals from September 2018 through May 2020. A 23-item safety check excluded patients with ongoing signs of systemic infection, concerning or inadequate microbiologic data, or high-risk conditions. Eligible patients were randomized to the opt-out protocol vs usual care. Primary outcome was post-enrollment antibacterial days of therapy (DOT). Clinicians caring for intervention patients were contacted to encourage antibiotic discontinuation using opt-out language. If continued, clinicians discussed the rationale for continuing antibiotics and de-escalation plans. To evaluate those with zero post-enrollment DOT, hurdle models provided 2 measures: odds ratio of antibiotic continuation and ratio of mean DOT among those who continued antibiotics.

Results

Among 9606 patients screened, 767 (8%) were enrolled. Intervention patients had 32% lower odds of antibiotic continuation (79% vs 84%; odds ratio, 0.68; 95% confidence interval [CI], .47–.98). DOT among those who continued antibiotics were similar (ratio of means, 1.06; 95% CI, .88–1.26). Fewer intervention patients were exposed to extended-spectrum antibiotics (36% vs 44%). Common reasons for continuing antibiotics were treatment of localized infection (76%) and belief that stopping antibiotics was unsafe (31%). Thirty-day safety events were similar.

Conclusions

An antibiotic opt-out protocol that targeted patients with suspected sepsis resulted in more antibiotic discontinuations, similar DOT when antibiotics were continued, and no evidence of harm. Clinical Trials Registration NCT03517007.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsSepsisAdultHumansRandomized Controlled Trials as TopicMulticenter Studies as Topic

Stichwörter der Autor:innen

SEP-1antibioticantimicrobial stewardshipde-escalationsepsis

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine, Infectious Diseases, Duke University, Durham, North Carolina, USA.
  • Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.
  • Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
  • Department of Pharmacy, Southeastern Regional Medical Center, Lumberton, North Carolina, USA.
  • Department of Pharmacy, Piedmont Newnan Hospital, Newnan, Georgia, USA.
  • Department of Pharmacy, Piedmont Atlanta Hospital, Atlanta, Georgia, USA.

Zitieren

APA

Moehring, R. W., Yarrington, M. E., Warren, B. G., Lokhnygina, Y., Atkinson, E., Bankston, A., Collucio, J., David, M. Z., Davis, A. E., Davis, J., Dionne, B., Dyer, A. P., Jones, T. M., Klompas, M., Kubiak, D. W., Marsalis, J., Omorogbe, J., Orajaka, P., Parish, A., …, & Centers for Disease Control and Prevention’s Prevention Epicenters Program (2023). Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial. Clinical Infectious Diseases, 76(3), 433-442. https://doi.org/10.1093/cid/ciac787

Vancouver

Moehring RW, Yarrington ME, Warren BG, Lokhnygina Y, Atkinson E, Bankston A, et al. Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial. Clinical Infectious Diseases. 2023;76(3):433-442. doi:10.1093/cid/ciac787

BibTeX
@article{Moehring2023,
  author = {Moehring, Rebekah W and Yarrington, Michael E and Warren, Bobby G and Lokhnygina, Yuliya and Atkinson, Erica and Bankston, Allison and Collucio, Julia and David, Michael Z and Davis, Angelina E and Davis, Janice and Dionne, Brandon and Dyer, April P and Jones, Travis M and Klompas, Michael and Kubiak, David W and Marsalis, John and Omorogbe, Jacqueline and Orajaka, Patricia and Parish, Alice and Parker, Todd and Pearson, Jeffrey C and Pearson, Tonya and Sarubbi, Christina and Shaw, Christian and Spivey, Justin and Wolf, Robert and Wrenn, Rebekah H and Dodds Ashley, Elizabeth S and Anderson, Deverick J and Centers for Disease Control and Prevention’s Prevention Epicenters Program, Centers for Disease Control and Prevention’s Prevention Epicenters Program},
  title = {Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {433--442},
  doi = {10.1093/cid/ciac787}
}
Kostenlos starten →